From Targeted Oncology ... | IDRA Message Board Posts

Idera Pharmaceuticals, Inc

  IDRA website
  • Here We Go Again: Apparently, it's just one of those years. We here in the Greater New Orleans Area now find ourselves "in the cone" for the 7th time this year. And while we more or less dodged bullets the first 6 times, it looks like this time Zeta is going to hit close enough to do damage. We can only hope it stays a relatively minor Cat 1 & weakens upon approach. But preparations are once again in order for those of us living along the central Gulf Coast. Members with family or other interests in the affected area are welcome to post on the new Hurricane Zeta Self-Help board we just set up. Good luck & stay safe! 

IDRA   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1649 of 1667  at  6/8/2020 12:01:48 AM  by


 In response to msg 1646 by  auh2oman
view thread

Re: From Targeted Oncology ...

“One patient in the ILLUMINATE-206 study had stable disease. Of the 9 patients shown to have progressed on treatment, 6 developed stability or reduction in the size of their injected lesions. There were also 6 patients who showed stability or size reduction in uninjected lesions. In the initial safety cohort of the study, there were no treatment discontinuations due to adverse events (AEs). Also, no grade 4 or 5 AEs were observed in the study.“

Misleading. One had stable disease. None had regression. No complete responses. Did the six others reach stable disease or not? Per Beware of double speak. They did or they did not,

     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 140
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Financial Market Data provided by